- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana kicks off 2022 with Susan G. Komen[®] Orlando event
Dignitana, the world leader in scalp cooling innovation, will sponsor the Susan G. Komen® Orlando MORE THAN PINK Walk® on 5 March 2022. More than 1,200 cancer patients, survivors and supporters will gather for the event in Orlando, Florida to raise funds for breast cancer treatment, patient advocacy and lifesaving research.
Florida is one of the largest markets for Dignitana and The DigniCap Scalp Cooling system is available in over 45 locations in the state.
Dignitana is a proud supporter of Susan G. Komen and their mission to save lives by meeting the most critical needs in communities and investing in breakthrough research to prevent and cure breast cancer.
“Susan G. Komen is the world’s leading breast cancer organization, providing valuable resources and information to patients worldwide. We are honored to support the important work they do as we continue to increase awareness of scalp cooling in the breast cancer community and beyond,” said William Cronin, CEO of Dignitana.
Since its founding, Komen has funded more than $1 billion in research and invested more than $2.3 billion to provide screening, diagnostics, education, treatment and psychosocial support to people in communities across the U.S. and in 60 countries worldwide.
For More Information Contact
Melissa Bourestom, VP Corporate Communications, firstname.lastname@example.org +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB +46 8 121 576 90, email@example.com. Learn more at www.dignitana.com or www.dignicap.com.